Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 02 04:00PM ET
4.35
Dollar change
+0.03
Percentage change
0.69
%
IndexRUT P/E- EPS (ttm)-4.48 Insider Own1.14% Shs Outstand26.05M Perf Week6.88%
Market Cap117.06M Forward P/E- EPS next Y-3.46 Insider Trans0.00% Shs Float25.80M Perf Month-17.61%
Income-112.88M PEG- EPS next Q-0.92 Inst Own33.05% Short Float14.55% Perf Quarter-32.35%
Sales0.20M P/S585.28 EPS this Y28.41% Inst Trans9.63% Short Ratio11.11 Perf Half Y-57.19%
Book/sh2.82 P/B1.54 EPS next Y20.76% ROA-75.21% Short Interest3.75M Perf Year-8.04%
Cash/sh3.15 P/C1.38 EPS next 5Y41.50% ROE-106.64% 52W Range3.85 - 14.75 Perf YTD-28.92%
Dividend Est.- P/FCF- EPS past 5Y13.49% ROI-135.08% 52W High-70.50% Beta0.75
Dividend TTM- Quick Ratio3.88 Sales past 5Y60.80% Gross Margin-1143.50% 52W Low12.99% ATR (14)0.26
Dividend Ex-Date- Current Ratio3.88 EPS Y/Y TTM40.70% Oper. Margin-58709.67% RSI (14)37.14 Volatility4.92% 5.89%
Employees122 Debt/Eq0.17 Sales Y/Y TTM-76.18% Profit Margin-55491.09% Recom2.00 Target Price10.67
Option/ShortYes / Yes LT Debt/Eq0.14 EPS Q/Q41.00% Payout- Rel Volume0.95 Prev Close4.32
Sales Surprise-100.00% EPS Surprise22.61% Sales Q/Q-100.00% EarningsNov 14 AMC Avg Volume337.65K Price4.35
SMA20-7.00% SMA50-17.11% SMA200-49.23% Trades Volume320,611 Change0.69%
Date Action Analyst Rating Change Price Target Change
May-14-24Initiated Stephens Overweight $20
Jan-25-24Upgrade Oppenheimer Perform → Outperform $4
Nov-09-22Downgrade Maxim Group Buy → Hold
Nov-01-22Downgrade BofA Securities Neutral → Underperform $2
Jul-19-22Resumed RBC Capital Mkts Sector Perform $5 → $4
May-11-22Downgrade Oppenheimer Outperform → Perform
Jan-21-22Upgrade BofA Securities Underperform → Neutral $8 → $10
Dec-29-21Resumed Jefferies Hold $8 → $6
Sep-10-21Downgrade BofA Securities Neutral → Underperform $9 → $8
Jun-24-21Initiated Jefferies Hold $9
Nov-29-24 04:02PM
Nov-15-24 02:15AM
02:08AM
Nov-14-24 09:15PM
04:27PM
04:05PM Loading…
04:05PM
Nov-13-24 08:00AM
Nov-06-24 04:05PM
08:00AM
Oct-21-24 08:00AM
Oct-09-24 05:38AM
Oct-02-24 04:15PM
Oct-01-24 08:00AM
Sep-17-24 04:30PM
Sep-04-24 08:30AM
02:30AM Loading…
Aug-09-24 02:30AM
Aug-08-24 04:40PM
04:05PM
Aug-01-24 04:05PM
Jul-25-24 04:05PM
08:00AM
Jul-12-24 10:09AM
09:28AM
Jul-11-24 08:00AM
Jul-02-24 04:05PM
Jul-01-24 04:00PM
08:00AM
Jun-04-24 08:00AM
May-31-24 04:48PM
May-22-24 09:45AM
08:21AM Loading…
May-14-24 08:21AM
07:55AM
03:02AM
May-13-24 09:45PM
08:55PM
04:28PM
04:05PM
May-05-24 08:54AM
May-01-24 08:00AM
Apr-29-24 08:00AM
08:00AM
Apr-15-24 06:39PM
Mar-26-24 06:28PM
Mar-08-24 09:55AM
Mar-07-24 10:38AM
06:39AM
Mar-06-24 11:30PM
09:54PM
04:05PM
07:00AM
Feb-21-24 09:55AM
08:00AM
Feb-12-24 06:25AM
Feb-07-24 11:46AM
Feb-02-24 08:00AM
Jan-30-24 09:55AM
Jan-24-24 09:13AM
Jan-23-24 08:00AM
Jan-22-24 08:00AM
Jan-12-24 09:43AM
Jan-04-24 08:00AM
Jan-03-24 08:00AM
Nov-14-23 10:56AM
Nov-10-23 03:38PM
12:00AM
Nov-09-23 04:42PM
04:05PM
Nov-01-23 08:00AM
Oct-26-23 08:00AM
Oct-19-23 09:53AM
Oct-10-23 08:00AM
Sep-28-23 11:10AM
Sep-27-23 07:39PM
Sep-07-23 08:00AM
Sep-06-23 09:31PM
Aug-29-23 08:00AM
Aug-09-23 08:30PM
05:40PM
04:38PM
04:05PM
Aug-04-23 08:00AM
Jul-26-23 09:32AM
Jun-23-23 04:10PM
Jun-01-23 08:00AM
May-25-23 08:00AM
May-23-23 04:13PM
May-15-23 12:00PM
06:08AM
May-13-23 08:20AM
May-12-23 06:14AM
May-11-23 03:30AM
May-10-23 05:45PM
04:05PM
May-08-23 08:00AM
May-05-23 08:00AM
Apr-28-23 08:00AM
Apr-27-23 08:00AM
Apr-26-23 08:00AM
Apr-17-23 01:55PM
08:00AM
Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.